Clinicogenomic Landscape of Histologic Subtypes in Ovarian Cancer: Real-World Evidence From a Japanese Nationwide Cohort
Ryuji Tamaki, Hiroyuki Kogai, Koji Sagane, Ken Aoshima, Shuyu D. Li · 2026
Read Clinicogenomic Landscape of Histologic Subtypes in Ovarian Cancer: Real-World Evidence From a Japanese Nationwide Cohort by Ryuji Tamaki, Hiroyuki Kogai, Koji Sagane, Ken Aoshima, Shuyu D. Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13268116.txt.
Description
Ryuji Tamaki and colleagues report a 2026 study of ovarian cancer subtypes in a nationwide Japanese database. The mix of subtypes differs by region: clear cell cancer is far more common in Asia than in the West. The team analyzed real-world records and gene profiles for 5,395 patients diagnosed between 2016 and 2025.
High-grade serous cancer made up 51 percent and clear cell cancer 30 percent, a much higher clear cell share than Western cohorts show. Each subtype carried its own gene pattern. The common cancer gene TP53 was altered in 94 percent of the high-grade serous group, while other subtypes leaned on different genes. Some gene traits predicted longer or shorter survival, varying by subtype. Changes appearing after treatment hinted at an iron-based cell death route of drug resistance.
Catalog record
| CREATOR | Ryuji Tamaki, Hiroyuki Kogai, Koji Sagane, Ken Aoshima, Shuyu D. Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29951 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |